• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials.

作者信息

Senn S

出版信息

Stat Med. 1994 Feb 15;13(3):293-6. doi: 10.1002/sim.4780130310.

DOI:10.1002/sim.4780130310
PMID:8202653
Abstract
摘要

相似文献

1
Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials.临床试验荟萃分析中总体比值比解释趋势的重要性。
Stat Med. 1994 Feb 15;13(3):293-6. doi: 10.1002/sim.4780130310.
2
Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials.
Stat Med. 1992 Dec;11(16):2077-82. doi: 10.1002/sim.4780111605.
3
Meta-analysis and the reversed Theorem of the Means.Meta 分析与均值逆定理。
Res Synth Methods. 2014 Dec;5(4):313-21. doi: 10.1002/jrsm.1118. Epub 2014 May 23.
4
Meta-analysis: reconciling the results of independent studies.荟萃分析：整合独立研究的结果。
Stat Med. 1995;14(5-7):457-72. doi: 10.1002/sim.4780140507.
5
Meta-regression approximations to reduce publication selection bias.元回归逼近法可减少发表偏倚。
Res Synth Methods. 2014 Mar;5(1):60-78. doi: 10.1002/jrsm.1095. Epub 2013 Sep 3.
6
Use of re-randomized data in meta-analysis.在荟萃分析中使用重新随机化的数据。
BMC Med Res Methodol. 2005 May 10;5:17. doi: 10.1186/1471-2288-5-17.
7
Re: "A critical look at some popular meta-analytic methods".关于：“对一些流行的荟萃分析方法的批判性审视”。
Am J Epidemiol. 1994 Aug 1;140(3):297-9; discussion 300-1. doi: 10.1093/oxfordjournals.aje.a117249.
8
Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses.不可言传的知识？解读与应用临床试验及荟萃分析的结果。
J Clin Epidemiol. 1998 Apr;51(4):289-95. doi: 10.1016/s0895-4356(97)00293-x.
9
What have we learned from meta-analysis?
Med J Aust. 1993 Sep 6;159(5):291-3. doi: 10.5694/j.1326-5377.1993.tb137859.x.
10
A finite mixture method for outlier detection and robustness in meta-analysis.一种用于荟萃分析中异常值检测和稳健性的有限混合方法。
Res Synth Methods. 2014 Dec;5(4):285-93. doi: 10.1002/jrsm.1114. Epub 2014 Mar 6.

引用本文的文献

1
Randomization and placebo effects in clinical trials of major depressive disorder.重度抑郁症临床试验中的随机化与安慰剂效应。
Transl Psychiatry. 2025 Feb 5;15(1):43. doi: 10.1038/s41398-025-03263-0.
2
Measurement errors in control risk regression: A comparison of correction techniques.控制风险回归中的测量误差：校正技术比较。
Stat Med. 2022 Jan 15;41(1):163-179. doi: 10.1002/sim.9228. Epub 2021 Oct 15.
3
Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 2: Is the Odds Ratio "portable" in meta-analysis? Time to consider bivariate generalized linear mixed model.
争议与辩论：相对风险在临床研究中的效用值得质疑：第 2 篇：比值比在荟萃分析中是否“可移植”？是时候考虑双变量广义线性混合模型了。
J Clin Epidemiol. 2022 Feb;142:280-287. doi: 10.1016/j.jclinepi.2021.08.004. Epub 2021 Aug 9.
4
Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: a meta-epidemiological study.多数基于汇总数据的发表的荟萃回归分析存在方法学缺陷：一项荟萃流行病学研究。
BMC Med Res Methodol. 2021 Jun 15;21(1):123. doi: 10.1186/s12874-021-01310-0.
5
Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy.神经病理性疼痛临床试验：与估计药物疗效下降相关的因素。
Pain. 2018 Nov;159(11):2339-2346. doi: 10.1097/j.pain.0000000000001340.
6
Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis.解释患者决策辅助工具对结果概率知晓度影响异质性的因素：一项系统评价亚分析
Syst Rev. 2013 Oct 21;2:95. doi: 10.1186/2046-4053-2-95.
7
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.随机对照试验报告中中期数据的使用及数据监测委员会的建议：频率、影响及潜在偏差来源
BMC Med Res Methodol. 2008 Mar 20;8:12. doi: 10.1186/1471-2288-8-12.
8
Statins for primary prevention: at what coronary risk is safety assured?他汀类药物用于一级预防：在何种冠心病风险水平下安全性可得到保证？
Br J Clin Pharmacol. 2001 Oct;52(4):439-46. doi: 10.1046/j.0306-5251.2001.01478.x.
9
Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandoned.荟萃分析中治疗获益与潜在风险之间的关系。不应放弃“标签不变性”标准。
BMJ. 1996 Dec 14;313(7071):1550-1. doi: 10.1136/bmj.313.7071.1550a.
10
The relation between treatment benefit and underlying risk in meta-analysis.荟萃分析中治疗获益与潜在风险之间的关系。
BMJ. 1996 Sep 21;313(7059):735-8. doi: 10.1136/bmj.313.7059.735.